...
首页> 外文期刊>Archives of Toxicology >Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
【24h】

Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes

机译:使用人诱导的多能干细胞衍生心肌细胞的化妆品的功能性心脏毒性评估

获取原文
获取原文并翻译 | 示例

摘要

There is a large demand of a human relevant in vitro test system suitable for assessing the cardiotoxic potential of cosmetic ingredients and other chemicals. Using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), we have already established an in vitro cardiotoxicity assay and identified genomic biomarkers of anthracycline-induced cardiotoxicity in our previous work. Here, five cosmetic ingredients were studied by the new hiPSC-CMs test; kojic acid (KJA), triclosan (TS), triclocarban (TCC), 2,7-naphthalenediol (NPT), and basic red 51 (BR51) based on cytotoxicity as well as ATP assays, beating rate, and genomic biomarkers to determine the lowest observed effect concentration (LOEC) and no observed effect concentration (NOEC). The LOEC for beating rate were 400, 10, 3, 400, and 3 mu M for KJA, TS, TCC, NPT, and BR51, respectively. The corresponding concentrations for cytotoxicity or ATP depletion were similar, with the exception of TS and TCC, where the cardiomyo-cyte-beating assay showed positive results at non-cytotoxic concentrations. Functional analysis also showed that the individual compounds caused different effects on hiPSC-CMs. While exposure to KJA, TS, TCC, and BR51 induced significant arrhythmic beating, NPT slightly decreased cell viability, but did not influence beating. Gene expression studies showed that TS and NPT caused down-regulation of cytoskeletal and cardiac ion homeostasis genes. Moreover, TS and NPT deregulated genomic biomarkers known to be affected also by anthracyclines. The present study demonstrates that hiPSC-CMs can be used to determine LOECs and NOECs in vitro, which can be compared to human blood concentrations to determine margins of exposure. Our in vitro assay, which so far has been tested with several anthracyclines and cosmetics, still requires validation by larger numbers of positive and negative controls, before it can be recommended for routine analysis.
机译:人类相关的体外测试系统有很大的需求,适用于评估化妆品成分和其他化学品的心脏毒性潜力。使用人诱导的多能干细胞衍生的心肌细胞(HIPSC-CM),我们已经建立了在我们以前的工作中鉴定了蒽环霉素诱导的心脏毒性的基因组生物标志物。在这里,通过新的HIPSC-CMS测试研究了五种化妆品成分; Kojic acid(kja),三氯烷(ts),三萘甲板(tcc),2,7-萘二醇(npt),基于细胞毒性以及ATP测定,跳动率和基因组生物标志物的碱性红色51(BR51),以确定最低观察到的效果浓度(LOEC),没有观察到的效果浓度(NOEC)。用于跳动率的LOEC分别为400,10,3,& 400,30m,以及KJA,TS,TCC,NPT和BR51的3μm。具有TS和TCC的细胞毒性或ATP耗尽的相应浓度与TS和TCC除外,其中心肌卵细胞谱系测定结果显示出非细胞毒性浓度的阳性结果。功能分析还表明,各种化合物对HIPSC-CM产生了不同的影响。虽然接触KJA,TS,TCC和BR51诱导显着的心律失常搏动,但NPT略微降低细胞活力,但没有影响跳动。基因表达研究表明,TS和NPT导致细胞骨骼和心脏离子稳态基因的下调。此外,已知的Ts和NPT危险的基因组生物标志物也受到蒽环类的影响。本研究表明,HIPSC-CMS可用于在体外测定LOECS和NOECS,其可以与人血浓度进行比较以确定暴露的边缘。我们的体外测定,到目前为止已经用几种蒽环类和化妆品测试,仍需要通过较大数量的正和阴性对照进行验证,以便在建议进行常规分析之前。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号